A Dangerous Curve: Impact of the COVID-19 Pandemic on Brace Treatment in Adolescent Idiopathic Scoliosis.

Pereira Duarte, Matias; Joncas, Julie; Parent, Stefan; Duval, Mylène; Chémaly, Olivier; Brassard, Félix; Mac-Thiong, Jean-Marc; Barchi, Soraya et al. · Global Spine J · 2024

retrospective_cohort · Level III

Where this comes from

Abstract

Observational Cohort study. We aim to document the abandon and irregular compliance rate towards brace treatment during the COVID-19 pandemic and its impact on AIS progression. We reviewed a database of AIS patients recruited between March and September 2020. We included AIS patients under brace treatment according to SRS criteria. The patients were divided in 2 cohorts: those with self-reported Good-Compliance (GC) to treatment and those who had a Bad-Compliance (BC). Data analysis included biometric and radiographic data at first visit and last follow-up and percentage of progression. Unpaired student-t tests and Chi<sup>2</sup> were used for comparison. 152 patients met inclusion criteria. 89 patients (age:12.1y.o.±1.4) reported good adherence to treatment, while 63 patients (age:12.7y.o.±1.8) were not compliant. Within the BC group, 18 patients reported irregular brace wear, while 45 had completely abandoned treatment (abandon rate of 29%). The GC cohort started treatment with a mean main thoracic (MT) curve of 26° and finished with 27°. The mean difference between measurements was +.65°±7.5; mean progression rate was -<b>4.6%.</b> However, the BC cohort started with a mean MT curve of 27° and finished with 32°, with a mean increase of +5<b>°</b>±8 and a mean progression rate of -<b>13%.</b> The differences between the 2 cohorts were statistically significant (<i>P</i> = .0002). Six patients from the BC group progressed and were offered surgery. The abandon rate of brace treatment in AIS significantly increased during the first wave of COVID-19 pandemic. Patients who voluntarily discontinued treatment had significant increases in curve progression and surgical indication rates. III.